Coming Soon! Therapeutic Tolerance Workshop 27-30th June 2017

 

Therapeutic Tolerance Workshop 27-30^th June 2017

 

Confirmed speakers

R Germain (Bethesda, USA) Keynote address: Imaging the immune system   G Hollander (Oxford, UK) The thymus – an update   E Shevach (Bethesda, USA) Regulatory T cells   F Powrie (Oxford, UK) Manipulating the microbiome for tolerance induction   D Sansom (London, UK) What does CTLA4 really do?   S Khleif (Augusta, USA) Title TBC   T Johnson (Augusta, USA) Trials and tribulations in breaking tumour tolerance   PP Tak (Stevenage, UK) Immunomodulation by vagal nerve stimulation   H Jonuleit (Mainz, Germany) Tolerogenic targets in regulatory T cells   I Anegon (Nantes, France) Novel mechanisms in tolerance induction   J Isaacs (Newcastle, UK) Update on the RA-MAP consortium   M Hernandez-Fuentes (London, UK) Biomarkers in transplantation tolerance   G Kassiotis (London, UK) Endogenous retroviruses and the breakdown of immune tolerance   G Lombardi (London, UK) Tregs in kidney transplantation   R Thomas (Brisbane Australia) A platform for peptide therapeutics   G Schett (Erlangen, Germany) Autoantibodies as tolerance biomarkers   M Trucco (Pittsburgh, USA) Tolerogenic therapies for type I diabetes   A Cope (London, UK) Treating very early autoimmunity   M Rosenzwajg (Paris, France) Low dose IL-2 therapy

L Chatenoud (Paris, France) Anti-CD3 – an update   A Coles (Cambridge, UK) Alemtuzumab in Multiple Sclerosis   M Ehrenstein (London, UK) Anti-TNF as a tolerogenic therapy   A Mellor (Newcastle, UK) IDO and tolerance – where are we now?   D Howie (Oxford, UK) How FoxP3 regulates immune metabolism   L Graca (Lisbon, Portugal) Tolerance to Factor VIII   H Waldmann (Oxford, UK) Novel antibodies with improved properties?   J van Laar (Utrecht, The Netherlands) Hematologic transplantation as a therapy for autoimmunity   A Radbruch (Berlin, Germany) Restoring B cell tolerance   F van Wijk (Utrecht, The Netherlands) Resetting T cell regulation in JIA   M Bernardo (Milan, Italy) Mesenchymal for tolerance induction   D Wraith (Birmingham, UK) Peptide therapy in MS and other conditions   L Klareskog (Stockholm, Sweden) Evolution of an autoimmune disease   P Trzonkowski (Gdansk, Poland) Treg therapies in type I diabetes   C Mauri (London, UK) Regulator B Cells   K Kishimoto (Massachusetts , USA) Tolerogenic nanoparticles   R Wilkinson (Cambridge, UK) Title TBC   D Vignali (Pittsburgh, USA) Title TBC   M Peakman (London, UK) Peptide therapy in diabetes